BenevolentAI, founded in 2013, creates and applies AI technologies to transform the way medicines are discovered and developed. BenevolentAI seeks to improve patient’s lives by applying technology designed to generate better data decision making and in doing so lower drug development costs, decrease failure rates and increase the speed at which medicines are generated. The company has developed the Benevolent Platform™ - a discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients.BenevolentAI is HQ’d in London with a research facility in Cambridge (UK) and further offices in New York and Antwerp. BenevolentAI has active R&D drug programmes from discovery to PhaseIIb in disease areas such as ALS, Parkinson’s, Ulcerative Colitis and Sarcopenia.
BenevolentAI (BAI) has five openings for biological scientists with experience in leading drug discovery programmes. These individuals, depending on experience, will provide either overall or biology leadership of technology-enabled small molecule drug discovery programmes, from hit identification right through to preclinical stages. In addition, new colleagues will be expected to participate in the use of the BAI target identification platform to identify additional targets to seed our expanding portfolio.
As a central member of a dynamic, multi-disciplinary team of scientists passionate about the potential of technology assisted drug discovery and development, you will bring your proven resilient leadership and ability to make pragmatic data driven decisions to advance our ever expanding portfolio of small molecule programs and target identification deployments. Based at our London offices off Tottenham Court Road or the Babraham Research Campus in Cambridge (UK), you will work closely with a diverse range of experts in biological sciences, chemical sciences, clinical, commercialisation, artificial intelligence (AI), deep/machine learning (ML) and informatics teams to enrich the BAI portfolio.
Provide leadership for small molecule drug discovery programs from hit identification through to preclinical development
We are an eclectic bunch at Benevolent, united by our belief that innovative thinking and purposeful technology can truly change outcomes for the better. Our mission is to re-engineer drug discovery and deliver life-changing medicines for patients in need and we do this by applying AI, machine learning and other advanced technologies to reinvent the ways drugs are discovered and developed. We strive to bring together unique skills and perspectives across biology, chemistry, engineering, AI research, informatics, precision medicine and drug discovery. Together, we envision a world in which no disease goes untreated. If you are benevolent, curious, want to tackle real world problems and are willing to embrace new ideas, hit that ‘apply’ button and join us.
It has come to our attention that unfortunately fraudsters have been falsely offering jobs and set-up fake interviews under the guise of being a Benevolent recruiter. We therefore advise you to be very stringent about who is reaching out to you. Any enquiry from our team will only be made via the email email@example.com or an email from this domain @benevolent.ai. Please flag any suspicious contact request to firstname.lastname@example.org